LBTSF (Almirall) Marketable Securities: $0 Mil (As of Mar. 2026)


LBTSF Almirall SA LBTSF
84 GF Score
Price $15.35
GF Value $16.66
! 4 Warning Signs
View Full Analysis

What is Almirall Marketable Securities?

Almirall LBTSF 84 Marketable Securities is $0 Mil as of Mar. 2026. GuruFocus rates LBTSF with a GF Score™ of 84/100 and a GF Value™ of $16.66. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Almirall's Marketable Securities for the quarter that ended in Mar. 2026 was $0 Mil.

Almirall's annual Marketable Securities increased from Dec. 2023 ($0 Mil) to Dec. 2024 ($0 Mil) and increased from Dec. 2024 ($0 Mil) to Dec. 2025 ($1 Mil).

Almirall  (OTCPK:LBTSF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Almirall Marketable Securities Related Terms

Almirall Marketable Securities Historical Data

* Premium members only.

The historical data trend for Almirall's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Marketable Securities Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 0.00 0.15 0.21 1.23

Almirall Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.33 0.00 1.23 0.00
LBTSF
84GF Score
Almirall SA LBTSF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almirall Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0 Mil mean?
Almirall (LBTSF) has a Marketable Securities of $0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Almirall and its competitors.
Is Almirall's Marketable Securities too high?
Almirall's current Marketable Securities is $0 Mil. Overall, Almirall has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Marketable Securities compare to ZTS and UTHR?
Almirall's Marketable Securities of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Almirall and its competitors. Almirall's current Marketable Securities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Marketable Securities of $0 Mil. The stock's GF Value™ is $16.66, compared to a current price of $15.35 — trading 7.9% below its estimated fair value. The current Marketable Securities is $0 Mil. Almirall's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Almirall (LBTSF), the current Marketable Securities is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 7.9% below its estimated GF Value™ of $16.66.

Key valuation signals for LBTSF:

  • Marketable Securities: $0 Mil
  • GF Value™: $16.66 vs. price of $15.35 (7.9% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
84GF Score

Get the complete analysis for LBTSF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$16.66
GF Value